Trial intelligence / Profile preview

Tranilast and Allopurinol in Hyperuricemia

NCT01052987Phase 2Completed

Sponsor
Nuon Therapeutics, Inc.
Start
Jan 2010
Primary completion
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tranilast in hyperuricemia, sponsored by Nuon Therapeutics, Inc.. Started Jan 2010; status: completed.

02

Drugs

tranilast
03

Conditions

hyperuricemia

Beyond the preview

Go deeper on NCT01052987.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01052987.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call